Arfip2tm1d(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
Arfip2tm1d(EUCOMM)Wtsi |
Name: |
ARF interacting protein 2; targeted mutation 1d, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:7611851 |
Gene: |
Arfip2 Location: Chr7:105283410-105289623 bp, - strand Genetic Position: Chr7, 55.92 cM, cytoband F1
|
Alliance: |
Arfip2tm1d(EUCOMM)Wtsi page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:345639
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutations: |
|
Insertion, Intragenic deletion
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 105286613 of Chromosome 7 upstream of the critical exons 4-5 (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exons 4-5 at position 105287999. The critical exons 4-5 are thus flanked by loxP sites. Flp-mediated recombination removed the lacZ and neomycin resistance gene creating a conditional ready (floxed) allele. Exons 4-5 were removed via cre-mediated recombination in the germline generating a knock-out mouse. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml.
(J:345639)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Arfip2 Mutation: |
21 strains or lines available
|
|
Original: |
J:345639 Guo H, et al., ADP-Ribosylation Factor-Interacting Protein 2 Acts as a Novel Regulator of Mitophagy and Autophagy in Podocytes in Diabetic Nephropathy. Antioxidants (Basel). 2024 Jan 8;13(1) |
All: |
1 reference(s) |
|